SG11202112479UA - Methods and compositions comprising staphylococcus protein a (spa) variants - Google Patents

Methods and compositions comprising staphylococcus protein a (spa) variants

Info

Publication number
SG11202112479UA
SG11202112479UA SG11202112479UA SG11202112479UA SG11202112479UA SG 11202112479U A SG11202112479U A SG 11202112479UA SG 11202112479U A SG11202112479U A SG 11202112479UA SG 11202112479U A SG11202112479U A SG 11202112479UA SG 11202112479U A SG11202112479U A SG 11202112479UA
Authority
SG
Singapore
Prior art keywords
spa
variants
compositions
methods
staphylococcus protein
Prior art date
Application number
SG11202112479UA
Other languages
English (en)
Inventor
Olaf Schneewind
Dominique Missiakas
Yan Sun
Hwan Keun Kim
Miaomiao Shi
Xinhai Chen
Original Assignee
Univ Chicago
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Chicago filed Critical Univ Chicago
Publication of SG11202112479UA publication Critical patent/SG11202112479UA/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/085Staphylococcus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/305Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
    • C07K14/31Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/545Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/55Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
SG11202112479UA 2019-05-14 2020-05-13 Methods and compositions comprising staphylococcus protein a (spa) variants SG11202112479UA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962847832P 2019-05-14 2019-05-14
PCT/US2020/070048 WO2020232471A2 (en) 2019-05-14 2020-05-13 Methods and compositions comprising staphylococcus protein a (spa) variants

Publications (1)

Publication Number Publication Date
SG11202112479UA true SG11202112479UA (en) 2021-12-30

Family

ID=73288805

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202112479UA SG11202112479UA (en) 2019-05-14 2020-05-13 Methods and compositions comprising staphylococcus protein a (spa) variants

Country Status (14)

Country Link
US (1) US20220323563A1 (he)
EP (1) EP3969031A4 (he)
JP (1) JP2022533096A (he)
KR (1) KR20220025724A (he)
CN (1) CN114340652A (he)
AU (1) AU2020273471A1 (he)
BR (1) BR112021022902A2 (he)
CA (1) CA3139981A1 (he)
CL (1) CL2021002992A1 (he)
CO (1) CO2021015337A2 (he)
IL (1) IL288060A (he)
MX (1) MX2021013833A (he)
SG (1) SG11202112479UA (he)
WO (1) WO2020232471A2 (he)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114315996B (zh) * 2021-12-31 2023-01-17 博格隆(浙江)生物技术有限公司 一种重组ProteinA蛋白及亲和层析介质的制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5952185B2 (ja) * 2010-03-24 2016-07-13 株式会社カネカ 免疫グロブリンに特異的に結合するタンパク質および免疫グロブリン結合性アフィニティーリガンド
SG186290A1 (en) * 2010-07-02 2013-01-30 Univ Chicago Compositions and methods related to protein a (spa) variants
US10065995B2 (en) * 2011-03-25 2018-09-04 Kaneka Corporation Protein for affinity-separation matrix
US20160074497A1 (en) * 2013-05-03 2016-03-17 The University Of Chicago Staphylococcus live cell vaccines
RU2017139797A (ru) * 2015-04-17 2019-05-17 Арсанис Байосайенсиз Гмбх Антитела, направленные против иммуноглобулин-связывающих белков s. aureus

Also Published As

Publication number Publication date
CN114340652A (zh) 2022-04-12
CA3139981A1 (en) 2020-11-19
MX2021013833A (es) 2022-03-17
EP3969031A4 (en) 2023-10-25
WO2020232471A3 (en) 2020-12-30
WO2020232471A2 (en) 2020-11-19
JP2022533096A (ja) 2022-07-21
US20220323563A1 (en) 2022-10-13
CL2021002992A1 (es) 2022-07-08
EP3969031A2 (en) 2022-03-23
BR112021022902A2 (pt) 2022-01-25
CO2021015337A2 (es) 2022-02-17
AU2020273471A1 (en) 2021-12-23
IL288060A (he) 2022-01-01
KR20220025724A (ko) 2022-03-03

Similar Documents

Publication Publication Date Title
GB201909190D0 (en) Therapeutic agents
GB201909194D0 (en) Therapeutic agents
GB201909191D0 (en) Therapeutic agents
EP3985014A4 (en) ANTIMICROBIAL PEPTIDES DERIVED FROM ROMO1 AND VARIANTS THEREOF
ZA202100859B (en) Recombinant protein variants
SG10202011314SA (en) Game system
DK3737402T3 (en) Modificeret protein
GB201902277D0 (en) Therapeutic agents
AU201814954S (en) Game timer
EP4013445A4 (en) THERAPEUTIC PROTEIN COMPOSITIONS AND METHODS
EP3898960A4 (en) VARIANTS OF HUMAN ALPHA GALACTOSIDASE
GB201906804D0 (en) Therapeutic agents
IL288060A (he) שיטות ותכשירים המכילים וואריאנטים של חלבון סטפילוקוקוס a
GB202204938D0 (en) Compounds comprising curcmin and basic amino acids
SG11202109418QA (en) Synergistic insecticidal combinations
GB2587214B (en) Construction toy
EP3747515C0 (en) GAME DEVICE
EP3862059C0 (en) MODULAR GAME
GB201806760D0 (en) Puzzle
GB2601975B (en) Game court
CA206036S (en) Trickshot game
CA198206S (en) Gameboard
CA188912S (en) Puzzle piece
GB202101825D0 (en) Protein
GB202101826D0 (en) Protein